Suppr超能文献

甲状腺嗜酸性细胞腺瘤和癌中DNA含量的流式细胞术分析。

Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid.

作者信息

Bronner M P, Clevenger C V, Edmonds P R, Lowell D M, McFarland M M, LiVolsi V A

机构信息

University of Pennsylvania School of Medicine, Philadelphia.

出版信息

Am J Clin Pathol. 1988 Jun;89(6):764-9. doi: 10.1093/ajcp/89.6.764.

Abstract

Paraffin-embedded surgical biopsy material from 17 Hürthle cell tumors of the thyroid was examined for DNA content by flow cytometry to assess the diagnostic and prognostic utility of ploidy determinations in these rare tumors. Both adenomas (11 cases) and carcinomas (6 cases) were studied. As a control for methods, ten randomly selected normal autopsy thyroids were analyzed, all of which demonstrated normal diploid DNA content. Among the Hürthle cell tumors, however, aneuploid peaks were present in six adenomas (55%) and in four carcinomas (67%). Similarly, polyploid DNA peaks in the absence of other aneuploid peaks were present in two adenomas and two carcinomas (18% and 33%, respectively). These findings demonstrate the limited value of aneuploidy or polyploidy as diagnostic features for malignancy in Hürthle cell tumors of the thyroid. As for prognosis, there does not appear to be any unfavorable prognostic significance for abnormal DNA content in histologically benign Hürthle cell tumors treated by surgical excision because no metastases or recurrences occurred in this group at a mean disease-free follow-up of 50 +/- 19 months for six aneuploid lesions and 19 +/- 7 months for two polyploid adenomas. Preliminary data suggest that aneuploidy may, however, have an important prognostic value for histologically defined Hürthle cell carcinomas, because the only patient to die from the tumor in this series had an aneuploid Hürthle carcinoma. Thus, the authors' data indicate that the diagnostic utility of DNA content in Hürthle cell tumors is extremely limited and that there does not appear to be any negative prognostic significance for aneuploidy in histologically defined Hürthle cell adenomas.

摘要

对17例甲状腺许特耳细胞肿瘤的石蜡包埋手术活检材料进行流式细胞术检测DNA含量,以评估这些罕见肿瘤中倍体测定的诊断和预后价值。研究了腺瘤(11例)和癌(6例)。作为方法对照,分析了10例随机选取的正常尸检甲状腺,所有这些甲状腺均显示正常的二倍体DNA含量。然而,在许特耳细胞肿瘤中,6例腺瘤(55%)和4例癌(67%)出现非整倍体峰。同样,在2例腺瘤和2例癌中分别出现了无其他非整倍体峰的多倍体DNA峰(分别为18%和33%)。这些发现表明,非整倍体或多倍体作为甲状腺许特耳细胞肿瘤恶性诊断特征的价值有限。至于预后,对于经手术切除治疗的组织学上良性的许特耳细胞肿瘤,DNA含量异常似乎没有任何不良预后意义,因为在该组中,6例非整倍体病变的平均无病随访期为50±19个月,2例多倍体腺瘤的平均无病随访期为19±7个月,均未发生转移或复发。然而,初步数据表明,非整倍体可能对组织学定义的许特耳细胞癌具有重要的预后价值,因为该系列中唯一死于肿瘤的患者患有非整倍体许特耳癌。因此,作者的数据表明,DNA含量在许特耳细胞肿瘤中的诊断价值极其有限,并且对于组织学定义的许特耳细胞腺瘤,非整倍体似乎没有任何负面预后意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验